Related references
Note: Only part of the references are listed.The presence of active von Willebrand factor under various pathological conditions
Evelyn Groot et al.
CURRENT OPINION IN HEMATOLOGY (2007)
Decreased ADAMTS13 activity in plasma from patients with thrombotic thrombocytopenic purpura
Toshihiko Kobayashi et al.
THROMBOSIS RESEARCH (2007)
vAcquired ADAMTS-13 deficiency in pediatric patients with severe sepsis
Trung C. Nguyen et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis
A. Y. Nossent et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
The catastrophic antiphospholipid (Asherson's) syndrome
Ronald A. Asherson
AUTOIMMUNITY REVIEWS (2006)
Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival
Sandra L. Haberichter et al.
BLOOD (2006)
High-avidity anti-β2 glycoprotein I antibodies highly correlate with thrombosis in contrast to low-avidity anti-β2 glycoprotein I antibodies
B. De Laat et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura
F Banno et al.
BLOOD (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light
H Yarranton et al.
TRANSFUSION (2005)
ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases
M Rieger et al.
BLOOD (2005)
Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions
JF Dong
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Proteolytic inactivation of ADAMTS13 by thrombin and plasmin
JTB Crawley et al.
BLOOD (2005)
An experimental model to study the in vivo survival of von Willebrand factor -: Basic aspects and application to the R1205H mutation
PJ Lenting et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies
MJ Nash et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease
PM Mannucci et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
High avidity anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome
S Cucnik et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Genetic defects leading to hereditary thrombotic thrombocytopenic purpura
K Kokame et al.
SEMINARS IN HEMATOLOGY (2004)
Mechanisms of disease - Thrombotic microangiopathies
JL Moake
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Medical progress: The antiphospholipid syndrome.
JS Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor
PM Mannucci et al.
BLOOD (2001)
Share Paper
